Cleared Traditional

K895897 - MANAN PROSTATIC BIOPSY NEEDLE

K895897 is an FDA 510(k) clearance for MANAN PROSTATIC BIOPSY NEEDLE, manufactured by Manan Medical Products, Inc.. The device is a Class 2 Gastroenterology & Urology device with product code FCG cleared through the Traditional 510(k) pathway after a 12-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1989
Decision
12d
Days
Class 2
Risk

K895897 is an FDA 510(k) clearance for the MANAN PROSTATIC BIOPSY NEEDLE. Classified as Biopsy Needle (product code FCG), Class II - Special Controls.

Submitted by Manan Medical Products, Inc. (Northbrook, US). The FDA issued a Cleared decision on October 18, 1989 after a review of 12 days - a notably fast clearance cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1075 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K895897

510(k) Number K895897 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 06, 1989
Decision Date October 18, 1989
Days to Decision 12 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
119d faster than avg
Panel avg: 131d · This submission: 12d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FCG Device Classification - Class 2, Special Controls

Product Code FCG Biopsy Needle
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1075
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FCG Biopsy Needle

All 132
Devices cleared under the same product code (FCG) and FDA review panel - the closest regulatory comparables to K895897.
BAUER TEMNO BIOPSY NEEDLE
K902319 · Proact, Ltd. · Sep 1990
INGRESS TECHNOLOGIES AUTO BX BIOPSY NEEDLE
K896932 · The Witmoore Group, Inc. · Jun 1990
BIOPSY NEEDLE GUIDE FOR ADMS ULTRASOUND PROBES
K895725 · Interson Corp. · Nov 1989
TRT (ACUSON) NEEDLE GUIDE KIT, STERILE
K892068 · Amedic USA · Aug 1989
PRO-CUT BIOPSY NEEDLE
K891777 · Teknar, Inc. · May 1989
ADMS BIOPSY NEEDLE
K890203 · Advanced Diagnostic Medical Systems, Inc. · Mar 1989